<Table 2>
 <caption text="

   Frequency of IgE reactivity to major HDM allergens in relation to clinical symptoms.
  
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="">
  </cell>
  <cell col="1" row="0" text="nDer p 1">
  </cell>
  <cell col="2" row="0" text="nDer p 2">
  </cell>
  <cell col="3" row="0" text="rDer p 2.0101">
  </cell>
  <cell col="4" row="0" text="rDer p 23">
  </cell>
  <cell col="5" row="0" text="nDer p 1 or nDer p 2">
  </cell>
  <cell col="6" row="0" text="rDer p 23 only">
  </cell>
  <cell col="7" row="0" text="Any">
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="All">
  </cell>
  <cell col="1" row="1" text="72.1%">
  </cell>
  <cell col="2" row="1" text="81.7%">
  </cell>
  <cell col="3" row="1" text="78.3%">
  </cell>
  <cell col="4" row="1" text="70.9%">
  </cell>
  <cell col="5" row="1" text="90.4%">
  </cell>
  <cell col="6" row="1" text="4.6%">
  </cell>
  <cell col="7" row="1" text="95.0%">
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="AA">
  </cell>
  <cell col="1" row="2" text="83.0%">
  </cell>
  <cell col="2" row="2" text="83.3%">
  </cell>
  <cell col="3" row="2" text="82.4%">
  </cell>
  <cell col="4" row="2" text="82.4%">
  </cell>
  <cell col="5" row="2" text="90.8%">
  </cell>
  <cell col="6" row="2" text="4.5%">
  </cell>
  <cell col="7" row="2" text="95.3%">
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="AR">
  </cell>
  <cell col="1" row="3" text="62.5%">
  </cell>
  <cell col="2" row="3" text="80.0%">
  </cell>
  <cell col="3" row="3" text="74.7%">
  </cell>
  <cell col="4" row="3" text="60.7%">
  </cell>
  <cell col="5" row="3" text="90.0%">
  </cell>
  <cell col="6" row="3" text="4.7%">
  </cell>
  <cell col="7" row="3" text="94.7%">
  </cell>
 </row>
 <statements>
  <statement id="1" text="nDer p 1 or nDer p 2 has same HDM allergens for All,AA,AR ." type="entailed">
  </statement>
  <statement id="2" text="rDer p 23 only ranges from 5.5% to 6.7%." type="refuted">
  </statement>
  <statement id="3" text="Positive IgE ELISA to either nDer p 1 or nDer p 2 was demonstrated in 90.4% of patients, while the frequency of HDM-APs developing sensitization to any of the studied allergens reached 95.0% of patients ( Table 2 )." type="entailed">
  </statement>
 </statements>
</Table 2>